The Olive Longevity Gap

Critically examines the anti-aging potential of extra virgin olive oil and its specific phenolic compounds, such as oleuropein and hydroxytyrosol. While cellular and animal models demonstrate that these substances can successfully target the hallmarks of aging, human clinical trials often yield inconsistent or statistically insignificant results. A primary obstacle is poor bioavailability, as the human body rapidly metabolizes these compounds into conjugates that may lack the same protective efficacy as the original molecules. Furthermore, the research is frequently undermined by methodological flaws, such as trials that are too short to measure long-term biological changes like telomere attrition. The report also highlights the significant influence of industry funding, which can lead to biased interpretations and the selective publication of positive data.